Floatz logo

DEXAMETHASONE

Follicular Lymphoma and Marginal Zone Lymphoma

Beijing Mabworks Biotech Co., Ltd.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Follicular Lymphoma and Marginal Zone Lymphoma cohort.

Asset / SponsorPhaseRating
cc-5013
Beijing Mabworks Biotech Co., Ltd.
Phase 3BB
Recombinant Humanized Monoclonal Antibody Mil62
Beijing Mabworks Biotech Co., Ltd.
Phase 1/2CCC

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →